Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Lambert

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
American Journal of Surgery|September 28, 2019
Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapyEliza W Beal, Ahmed Ahmed, Travis Grotz, et al.
Annals of Surgical Oncology|April 23, 2020
Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective StudyBenjamin D Powers, Seth Felder, Jula Veerapong, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 26, 2021
The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC CollaborativeNadege Fackche, Ryan K Schmocker, Boateng Kubi, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 21, 2019
Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative StudyTiffany C Lee, Koffi Wima, Jeffrey J Sussman, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 21, 2019
Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC CollaborativeNick C Levinsky, Mackenzie C Morris, Koffi Wima, et al.
The Journal of Surgical Research|July 5, 2020
Predictors of Non-home Discharge after Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyBoateng Kubi, Jonathan Gunn, Nadege Fackche, et al.
Journal of Surgical Oncology|October 1, 2020
A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPECRachel M Lee, Adriana C Gamboa, Michael K Turgeon, et al.
Journal of Clinical Medicine|March 14, 2020
Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective ReviewEliza W Beal, Lorena P Suarez-Kelly, Charles W Kimbrough, et al.
Annals of Surgical Oncology|October 12, 2019
Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC CollaborativeMohammad Y Zaidi, Rachel M Lee, Adriana C Gamboa, et al.
Annals of Surgical Oncology|June 28, 2019
Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC CollaborativeAdriana C Gamboa, Mohammad Y Zaidi, Rachel M Lee, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
American Journal of Surgery|September 28, 2019
Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapyEliza W Beal, Ahmed Ahmed, Travis Grotz, et al.
Annals of Surgical Oncology|April 23, 2020
Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective StudyBenjamin D Powers, Seth Felder, Jula Veerapong, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 26, 2021
The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC CollaborativeNadege Fackche, Ryan K Schmocker, Boateng Kubi, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 21, 2019
Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative StudyTiffany C Lee, Koffi Wima, Jeffrey J Sussman, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 21, 2019
Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC CollaborativeNick C Levinsky, Mackenzie C Morris, Koffi Wima, et al.
The Journal of Surgical Research|July 5, 2020
Predictors of Non-home Discharge after Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyBoateng Kubi, Jonathan Gunn, Nadege Fackche, et al.
Journal of Surgical Oncology|October 1, 2020
A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPECRachel M Lee, Adriana C Gamboa, Michael K Turgeon, et al.
Journal of Clinical Medicine|March 14, 2020
Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective ReviewEliza W Beal, Lorena P Suarez-Kelly, Charles W Kimbrough, et al.
Annals of Surgical Oncology|October 12, 2019
Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC CollaborativeMohammad Y Zaidi, Rachel M Lee, Adriana C Gamboa, et al.
Annals of Surgical Oncology|June 28, 2019
Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC CollaborativeAdriana C Gamboa, Mohammad Y Zaidi, Rachel M Lee, et al.
Pageof 7